Second-trimester maternal serum markers and placenta accreta

Prenatal Diagnosis

Volumn 32, Issue 10, 2012, Pages 1010-1012

  Dreux, Sophie ^a   Salomon, Laurent J ^b   Muller, Françoise ^a,b,c   Goffinet, François ^d,e   Oury, Jean François ^a   Study Group, Aba ^f   Sentilhes, Loïc ^e,g  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c University Paris Ile de France Ouest   (France)

^d ABA Study Group ^*  (France)

^e French Collaborative Conservative Treatment of Placenta Accreta Study Group   (France)

^f ABA Study Group   (United States)

^g ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; CASE CONTROL STUDY; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MATERNAL SERUM; PLACENTA ACCRETA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; PLACENTA ACCRETA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 84866972374     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3932     Document Type: Letter

References (10)

1. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006;107:927-41.
2. Lim P, Greenberg M, Edelson M, et al. Utility of ultrasound ans MRI in prenatal diagnosis of placenta accreta: a pilot study. AJR 2011;197:1506-13.
3. Esakoff TF, Sparks TN, Kaimal AJ, et al. Diagnosis and morbidity of placenta accreta. Ultrasound Obstet Gynecol 2011;37:324-7.
4. Zelop C, Nadel A, Frigoletto FD, et al. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1992;80:693-4.
5. Kupferminc MJ, Tamura RK, Wigton TR, et al. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993;82:266-9.
6. Hung TH, Shau WY, Hsieh CC, et al. Risk factors for placenta accreta. Obstet Gynecol 1999;93:545-50.
7. Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010;115:526-34.
8. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty years analysis. AJOG 2005;192:1458-61.
9. Warshak CR, Ramos GA, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010;115:65-9.
10. Hourrier S, Salomon LJ, Dreux S, Muller F. Screening for adverse pregnancy outcome at early gestational age. Clin Chim Acta 2010;411:1547-52.